Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medmen Enterprises Inc. C.MMEN

Alternate Symbol(s):  MMNFF

MedMen Enterprises Inc. is a retail cannabis company with an operational footprint in California, Nevada, Illinois, Massachusetts, and New York. The Company offers a robust selection of high-quality products, including MedMen-owned brands MedMen Red, Moss and LuxLyte, through its premium retail stores, proprietary delivery service, as well as curbside and instore pickup. MedMen Buds, a loyalty... see more

CSE:MMEN - Post Discussion

Medmen Enterprises Inc. > Medmen Posts Q4 Loss Of $46.2 Million
View:
Post by AwareInvestor on Sep 24, 2021 7:42am

Medmen Posts Q4 Loss Of $46.2 Million

Medmen Enterprises last night reminded investors why Canaccord Genuity had a long standing $0.00 price target on the name. The firm reported its fourth quarter financial results, posting $42.0 million in revenue for the three month period, along with a net loss of $46.2 million.
Comment by thegreattimario on Sep 26, 2021 1:55pm
They actually raised their target after this quarter saying basically saying mmen is on the right path and issued a hold rating on mmen.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities